Skip to content
GLP-1 Savers
Menu
Ranked #267 · Watch List

Claya review

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $299/mo

Save ~78% vs brand-name

From $299/mo (compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose.

How much does Claya cost?

The price Claya publishes is From $299/mo (compounded). We flag this one to watch: confirm the ongoing rate with Claya before you count on it, because a low first month can step up afterward. That works out about 78% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $299/mo (compounded)
Tirzepatide
From $299/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Claya scored on our six published factors. See the methodology.

Lowest Real Price52/100
No Teaser-Rate Bait72/100
Nationwide Availability45/100
Both Molecules98/100
Easy Cancellation95/100
Reputation73/100

Why it's a deal

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Read the fine print

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

The bottom line

Best for: Shoppers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Ranked #267 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Claya, out of 426 others we track.

Shopping Claya against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Claya, and every program that undercuts or outscores it — starting with Alegro Health, the closest match on score — is ranked on the Claya alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Claya's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals